Seno Medical Instruments

Seno Medical Instruments has developed and commercialized the Imagio® Opto-Acoustic/Ultrasound Breast Imaging System—a non-invasive diagnostic device that combines laser optics and ultrasound to provide real-time functional and anatomical images. The system aims to improve diagnostic confidence in distinguishing benign from malignant breast lesions while reducing unnecessary biopsies. Clinical studies have demonstrated its ability to downgrade risk classification for benign masses and provide critical prognostic information about tumor subtypes. The company’s technology has received FDA approval in the US and CE Marking in Europe.